FR2865938B1 - Formulation retard solide comprenant de l'acetate de triptoreline - Google Patents

Formulation retard solide comprenant de l'acetate de triptoreline

Info

Publication number: FR2865938B1
Authority: FR; France
Prior art keywords: solid delay; delay formulation; triptoreline acetate; triptoreline; acetate
Prior art date: 2004-02-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR0401109A

Other languages

English (en)

Other versions

FR2865938A1 (fr

Inventor

Cheikf Roland Cherif

Pujol Francesc Navarro

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ipsen Pharma SAS

Original Assignee

Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-05

Filing date

2004-02-05

Publication date

2006-06-02

2004-02-05 Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS

2004-02-05 Priority to FR0401109A priority Critical patent/FR2865938B1/fr

2005-01-27 Priority to TW094102537A priority patent/TWI399224B/zh

2005-02-04 Priority to BRPI0507326-0A priority patent/BRPI0507326A/pt

2005-02-04 Priority to HK07108741.8A priority patent/HK1101127B/xx

2005-02-04 Priority to MXPA06008617A priority patent/MXPA06008617A/es

2005-02-04 Priority to RU2006131705/15A priority patent/RU2399384C2/ru

2005-02-04 Priority to EP05717551A priority patent/EP1722820A1/fr

2005-02-04 Priority to JP2006551883A priority patent/JP2007520533A/ja

2005-02-04 Priority to ARP050100422A priority patent/AR047797A1/es

2005-02-04 Priority to CN2005800035442A priority patent/CN1913924B/zh

2005-02-04 Priority to PCT/FR2005/000248 priority patent/WO2005082418A1/fr

2005-02-04 Priority to CA002554870A priority patent/CA2554870A1/fr

2005-08-12 Publication of FR2865938A1 publication Critical patent/FR2865938A1/fr

2006-06-02 Application granted granted Critical

2006-06-02 Publication of FR2865938B1 publication Critical patent/FR2865938B1/fr

2006-07-11 Priority to IL176786A priority patent/IL176786A0/en

2006-08-07 Priority to US11/499,777 priority patent/US20070031500A1/en

2024-02-05 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000007787 solid Substances 0.000 title 1
VXKHXGOKWPXYNA-PGBVPBMZSA-N triptorelin Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 VXKHXGOKWPXYNA-PGBVPBMZSA-N 0.000 title 1
229960004824 triptorelin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Neurosurgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

FR0401109A 2004-02-05 2004-02-05 Formulation retard solide comprenant de l'acetate de triptoreline Expired - Fee Related FR2865938B1 (fr)

Priority Applications (14)

Application Number	Priority Date	Filing Date	Title
FR0401109A FR2865938B1 (fr)	2004-02-05	2004-02-05	Formulation retard solide comprenant de l'acetate de triptoreline
TW094102537A TWI399224B (zh)	2004-02-05	2005-01-27	含有曲普瑞林醋酸鹽之固體持續釋放調配物
CA002554870A CA2554870A1 (fr)	2004-02-05	2005-02-04	Formulation retard solide comprenant de l'acetate de triporeline
MXPA06008617A MXPA06008617A (es)	2004-02-05	2005-02-04	Formulacion solida de accion prolongada que comprende acetato de triptorelina.
RU2006131705/15A RU2399384C2 (ru)	2004-02-05	2005-02-04	Твердая композиция пролонгированного действия, содержащая ацетат трипторелина
EP05717551A EP1722820A1 (fr)	2004-02-05	2005-02-04	Formulation retard solide comprenant de l'acetate de triptoreline
JP2006551883A JP2007520533A (ja)	2004-02-05	2005-02-04	トリプトレリンアセテートを含有してなる持続性の固体組成物
ARP050100422A AR047797A1 (es)	2004-02-05	2005-02-04	Formulacion solida de liberacion sostenida que comprende acetato de triptorelina
BRPI0507326-0A BRPI0507326A (pt)	2004-02-05	2005-02-04	formulação sólida de ação retardada para administração parenteral
PCT/FR2005/000248 WO2005082418A1 (fr)	2004-02-05	2005-02-04	Formulation retard solide comprenant de l’acetate de triporeline
HK07108741.8A HK1101127B (en)	2004-02-05	2005-02-04	Long-acting solid formulation comprising triptorelin acetate
CN2005800035442A CN1913924B (zh)	2004-02-05	2005-02-04	包括醋酸曲普瑞林的固体缓释制剂
IL176786A IL176786A0 (en)	2004-02-05	2006-07-11	Long-acting solid formulation comprising triptorelin acetate
US11/499,777 US20070031500A1 (en)	2004-02-05	2006-08-07	Long-acting solid formulation comprising triptorelin acetate

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0401109A FR2865938B1 (fr)	2004-02-05	2004-02-05	Formulation retard solide comprenant de l'acetate de triptoreline

Publications (2)

Publication Number	Publication Date
FR2865938A1 FR2865938A1 (fr)	2005-08-12
FR2865938B1 true FR2865938B1 (fr)	2006-06-02

Family

ID=34778533

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR0401109A Expired - Fee Related FR2865938B1 (fr)	2004-02-05	2004-02-05	Formulation retard solide comprenant de l'acetate de triptoreline

Country Status (13)

Country	Link
US (1)	US20070031500A1 (fr)
EP (1)	EP1722820A1 (fr)
JP (1)	JP2007520533A (fr)
CN (1)	CN1913924B (fr)
AR (1)	AR047797A1 (fr)
BR (1)	BRPI0507326A (fr)
CA (1)	CA2554870A1 (fr)
FR (1)	FR2865938B1 (fr)
IL (1)	IL176786A0 (fr)
MX (1)	MXPA06008617A (fr)
RU (1)	RU2399384C2 (fr)
TW (1)	TWI399224B (fr)
WO (1)	WO2005082418A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1684782B1 (fr)	2003-10-03	2015-09-30	Thorn BioScience, LLC	Processus de synchronisation de l'ovulation pour la reproduction reglee sans detection des chaleurs
HRP20161785T1 (hr) *	2007-06-06	2017-03-10	Debiopharm Research & Manufacturing Sa	Farmaceutski pripravak sporog oslobađanja pripremljen od mikročestica
CA2758532C (fr) *	2009-04-23	2017-07-25	Pennatek, Llc	Procede et composition pour synchroniser le moment de l'insemination
EP2246063A1 (fr) *	2009-04-29	2010-11-03	Ipsen Pharma S.A.S.	Formulations à libération prolongée contenant des analogues de GnRH
CN102048699B (zh) *	2009-11-03	2012-11-07	长春金赛药业有限责任公司	一种注射用醋酸曲普瑞林的缓释微球的制备方法
WO2013083605A1 (fr) *	2011-12-05	2013-06-13	Ferring Bv	Composition pharmaceutique de triptoréline
KR20150095715A (ko)	2012-11-28	2015-08-21	제이비에스 유나이티드 애니멀 헬스투 엘엘씨	미경산돈에서 수정 시간을 동기화하기 위한 방법
CN105267153B (zh) *	2015-11-27	2018-05-11	上海苏豪逸明制药有限公司	一种曲普瑞林缓释微粒及其制备方法
CN105878174B (zh) *	2016-04-26	2021-06-29	广州帝奇医药技术有限公司	一种固体分散体及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH679207A5 (fr) *	1989-07-28	1992-01-15	Debiopharm Sa
GB9016885D0 (en) *	1990-08-01	1990-09-12	Scras	Sustained release pharmaceutical compositions
GB2246514B (en) *	1990-08-01	1993-12-15	Scras	Sustained release pharmaceutical compositions and the preparation of particles for use therein
DE4223169C1 (de) *	1992-07-10	1993-11-25	Ferring Arzneimittel Gmbh	Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe
US5569467A (en) *	1993-05-15	1996-10-29	Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.)	Process for the preparation of microballs and microballs thus obtained
DE19617137C1 (de) *	1996-04-29	1997-02-27	Henkel Kgaa	Verwendung von Copolymerestern für die Herstellung von Mikrosphären
US5945128A (en) *	1996-09-04	1999-08-31	Romano Deghenghi	Process to manufacture implants containing bioactive peptides
FR2756493B1 (fr) *	1996-12-02	2001-04-13	Delab	Dispositif d'administration locale de formulations solides ou semi-solides
US20020111603A1 (en) *	1996-12-02	2002-08-15	Societe De Conseils De Recherches Et D'application	Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
IT1304152B1 (it) *	1998-12-10	2001-03-08	Mediolanum Farmaceutici Srl	Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
CA2435415A1 (fr) *	2001-01-26	2002-08-01	Debio Recherche Pharmaceutique S.A.	Microparticules de polymere biodegradable encapsulant une substance biologiquement active et formulations pharmaceutiques a liberation prolongee contenant lesdites particules
GB0122113D0 (en) *	2001-09-11	2001-10-31	Astrazeneca Ab	Composition

2004
- 2004-02-05 FR FR0401109A patent/FR2865938B1/fr not_active Expired - Fee Related
2005
- 2005-01-27 TW TW094102537A patent/TWI399224B/zh not_active IP Right Cessation
- 2005-02-04 RU RU2006131705/15A patent/RU2399384C2/ru not_active IP Right Cessation
- 2005-02-04 JP JP2006551883A patent/JP2007520533A/ja active Pending
- 2005-02-04 WO PCT/FR2005/000248 patent/WO2005082418A1/fr not_active Ceased
- 2005-02-04 EP EP05717551A patent/EP1722820A1/fr not_active Withdrawn
- 2005-02-04 CA CA002554870A patent/CA2554870A1/fr not_active Abandoned
- 2005-02-04 AR ARP050100422A patent/AR047797A1/es not_active Application Discontinuation
- 2005-02-04 CN CN2005800035442A patent/CN1913924B/zh not_active Expired - Fee Related
- 2005-02-04 MX MXPA06008617A patent/MXPA06008617A/es active IP Right Grant
- 2005-02-04 BR BRPI0507326-0A patent/BRPI0507326A/pt not_active IP Right Cessation
2006
- 2006-07-11 IL IL176786A patent/IL176786A0/en unknown
- 2006-08-07 US US11/499,777 patent/US20070031500A1/en not_active Abandoned

Also Published As

Publication number	Publication date
RU2399384C2 (ru)	2010-09-20
TW200528143A (en)	2005-09-01
CA2554870A1 (fr)	2005-09-09
MXPA06008617A (es)	2006-08-28
JP2007520533A (ja)	2007-07-26
CN1913924A (zh)	2007-02-14
WO2005082418A1 (fr)	2005-09-09
CN1913924B (zh)	2011-11-09
HK1101127A1 (en)	2007-10-12
BRPI0507326A (pt)	2007-07-03
EP1722820A1 (fr)	2006-11-22
IL176786A0 (en)	2006-10-31
AR047797A1 (es)	2006-02-22
US20070031500A1 (en)	2007-02-08
RU2006131705A (ru)	2008-03-10
TWI399224B (zh)	2013-06-21
FR2865938A1 (fr)	2005-08-12

Publication	Publication Date	Title
FR23C1029I2 (fr)	2024-06-14	Compositions d'anticorps anti-ctla-4
FR21C1055I2 (fr)	2022-11-18	Composition comprenant un anticorps anti-interleukine 13
MA29014B1 (fr)	2007-11-01	Formulations d'anticorps
EP1720766A4 (fr)	2010-04-21	Soute d'aeronef
BRPI0511900A (pt)	2008-01-22	composições farmacêuticas
MA29090B1 (fr)	2007-12-03	Composes inhibiteurs de la phosphorylase du glycogene et compositions pharmaceutiques les comprenant
DK1812025T3 (da)	2012-10-22	Stabiliserede bakteriofagformuleringer
IL177168A0 (en)	2006-12-10	N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
MA27487A1 (fr)	2005-08-01	Preparation solide
PL1701698T3 (pl)	2008-03-31	Prasowana bezpośrednio kompozycja farmaceutyczna do podawania doustnego CCI-779
EP1747004A4 (fr)	2009-06-03	Compositions pharmaceutiques pour insuffisances metaboliques
FR2831433B1 (fr)	2008-06-20	Composition topique solide
EP1786437A4 (fr)	2010-12-08	Compositions ghb ameliorees
IL177073A0 (en)	2006-12-10	Hydroxy-6-heteroarylphenanthridine derivatives and pharmaceutical compositions containing the same
EP1825866A4 (fr)	2008-03-12	Preparation solide
DK2033629T3 (da)	2013-02-04	Fast farmaceutisk sammensætning omfattende valsartan
IL177496A0 (en)	2006-12-10	Amido-substituted hydroxy -6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
FR2865938B1 (fr)	2006-06-02	Formulation retard solide comprenant de l'acetate de triptoreline
DK1837019T3 (da)	2012-11-12	Orale dispergerbare farmaceutiske sammensætninger
DE602004018858D1 (de)	2009-02-26	Emulsionszusammensetzung
EP1767612A4 (fr)	2008-04-09	Composition de savon solide et savon solide
EP1495759A4 (fr)	2010-12-29	Composition de dispersion solide
DK1761130T3 (da)	2011-05-30	Emballeret pulversammensætning til bageri
IL177498A0 (en)	2006-12-10	Difluoroethoxy -substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
EP1786433A4 (fr)	2008-02-27	Derives de betulinol utilises en tant qu'agents anti-vih

Legal Events

Date	Code	Title	Description
2010-01-08	CA	Change of address
2010-01-08	CD	Change of name or company name
2014-11-21	ST	Notification of lapse	Effective date: 20141031